Suntrust Banks Inc. trimmed its holdings in Hologic, Inc. (NASDAQ:HOLX) by 98.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,072 shares of the medical equipment provider’s stock after selling 255,799 shares during the quarter. Suntrust Banks Inc.’s holdings in Hologic were worth $216,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of HOLX. Stanley Laman Group Ltd. boosted its stake in Hologic by 4.7% during the 4th quarter. Stanley Laman Group Ltd. now owns 125,732 shares of the medical equipment provider’s stock valued at $5,375,000 after purchasing an additional 5,639 shares in the last quarter. Ontario Teachers Pension Plan Board boosted its stake in Hologic by 12.6% during the 4th quarter. Ontario Teachers Pension Plan Board now owns 69,990 shares of the medical equipment provider’s stock valued at $2,992,000 after purchasing an additional 7,811 shares in the last quarter. American International Group Inc. boosted its stake in Hologic by 8.0% during the 4th quarter. American International Group Inc. now owns 107,449 shares of the medical equipment provider’s stock valued at $4,593,000 after purchasing an additional 7,982 shares in the last quarter. TCW Group Inc. bought a new position in Hologic during the 4th quarter valued at $547,000. Finally, Homrich & Berg bought a new position in Hologic during the 4th quarter valued at $219,000. 97.59% of the stock is owned by institutional investors and hedge funds.
In related news, Director Namal Nawana acquired 6,600 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was bought at an average price of $37.88 per share, for a total transaction of $250,008.00. Following the transaction, the director now owns 6,954 shares of the company’s stock, valued at $263,417.52. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 0.88% of the stock is currently owned by corporate insiders.
Shares of Hologic, Inc. (NASDAQ:HOLX) opened at $39.57 on Monday. Hologic, Inc. has a 52-week low of $35.33 and a 52-week high of $46.80. The company has a market capitalization of $10,942.26, a price-to-earnings ratio of 19.30, a PEG ratio of 1.78 and a beta of 0.84. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.98 and a current ratio of 1.25.
Hologic (NASDAQ:HOLX) last announced its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.55 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. Hologic had a return on equity of 20.07% and a net margin of 34.53%. The company had revenue of $791.10 million during the quarter, compared to the consensus estimate of $785.80 million. During the same quarter in the prior year, the firm earned $0.52 EPS. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. sell-side analysts forecast that Hologic, Inc. will post 2.25 earnings per share for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.